Informationen:
Fehler:
ID
31060
Beschreibung
Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT01099124
Link
https://clinicaltrials.gov/show/NCT01099124
Stichworte
Versionen (1)
- 16.07.18 16.07.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
16. Juli 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Non Small Cell Lung Cancer NCT01099124
Eligibility Non Small Cell Lung Cancer NCT01099124
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Non Small Cell Lung Cancer NCT01099124
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Age
Item
1. aged 18-70 years old;
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma TNM clinical staging | Therapy naive | Prior Chemotherapy Without TC Regimen
Item
2. patients with ⅲ/ⅳ nsclc confirmed by histopathology or cytology who ware naive or previous chemotherapy without tc regimen;
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0919936 (UMLS CUI [2])
C1514457 (UMLS CUI [3,1])
C0332288 (UMLS CUI [3,2])
C4522122 (UMLS CUI [3,3])
C3258246 (UMLS CUI [1,2])
C0919936 (UMLS CUI [2])
C1514457 (UMLS CUI [3,1])
C0332288 (UMLS CUI [3,2])
C4522122 (UMLS CUI [3,3])
Medical contraindication Absent Chemotherapy
Item
3. no contraindication for chemotherapy;
boolean
C1301624 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
ECOG performance status
Item
4. ecog performance scale 0-2;
boolean
C1520224 (UMLS CUI [1])
Antiangiogenesis therapy Absent
Item
5. no history of anti-angiogenesis therapy;
boolean
C0281318 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,2])
Informed Consent
Item
6. patients are voluntary to participate and sigh the informed contents.
boolean
C0021430 (UMLS CUI [1])
Antineoplastic Agents
Item
1. concurrent use of other anti-cancer agents;
boolean
C0003392 (UMLS CUI [1])
Hypersensitivity M2ES | Hypersensitivity Biological Factors
Item
2. allergic history to m2es and biological agents;
boolean
C0020517 (UMLS CUI [1,1])
C2985192 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0005515 (UMLS CUI [2,2])
C2985192 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0005515 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
3. pregnant or breast-feeding women;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Cancer Other
Item
4. with other malignancy;
boolean
C1707251 (UMLS CUI [1])
Cor pulmonale Severe
Item
5. with severe cardiopulmonary disease;
boolean
C0034072 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain Uncontrolled
Item
6. uncontrolled brain metastasis patients;
boolean
C0220650 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])
Condition Study Subject Participation Status Exclusion
Item
7. other conditions that are regarded for exclusion by the trialists.
boolean
C0348080 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])